Editor's Choice Study shows diet and exercise improve treatment outcomes for obese pediatric cancer patients September 26, 2017 Diet and exercise may improve treatment outcomes in paediatric cancer patients, according to a study…
Editor's Choice Discovery of a new genetic syndrome which predisposes the body to cancer September 26, 2017 Research led by Jordi Surrallés, professor of the Department of Genetics and Microbiology at the…
Breast Cancer MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer September 26, 2017 A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western…
Editor's Choice Pioneering ‘precision’ radiotherapy boosts prostate cancer survival September 26, 2017 A high-tech form of radiotherapy that shapes radiation beams to tumours can dramatically improve outcomes…
Breast Cancer Breast cancer study confirms the ‘Angelina Jolie’ effect September 26, 2017 By Timothy Malcolm, UNSW. A study into the “Jolie Effect” by Weill Cornell Medicine and UNSW Sydney…
Editor's Choice HPV screening is far more effective than Pap tests: results from world-first clinical trial September 20, 2017 A new study by Cancer Council NSW and the Victorian Cytology Service (VCS Ltd.) has…
Editor's Choice Handheld ‘pen’ may bring real-time cancer diagnosis to surgeons’ fingertips September 12, 2017 Scientists have developed a handheld probe capable of non-destructively distinguishing between tumours and healthy tissue…
Breast Cancer What mediates the beneficial effects of exercise on breast cancer outcomes? September 12, 2017 The ability of serum obtained from women with breast cancer immediately after finishing two hours…
Melanoma and Skin Cancer ESMO 2017: Adjuvant Nivolumab Superior to Ipilimumab in Surgically Resected Stage III/IV Melanoma September 12, 2017 Adjuvant nivolumab is superior to standard of care ipilimumab in patients with surgically resected stage…
Melanoma and Skin Cancer ESMO 2017: Combination Targeted Adjuvant Therapy Doubles Relapse-free Survival in Stage III Melanoma September 12, 2017 Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage…